Semaglutide and Tirzepatide cost-effectiveness compared for obesity, referencing SURMOUNT-5 trial data.
The Cost-Effectiveness of Semaglutide and Tirzepatide for Patients With Knee Osteoarthritis and Obesity.
Abstract
Cost-effectiveness of semaglutide vs. tirzepatide for obesity patients in the US was evaluated using SURMOUNT-5 trial data.
TitrateLab articles covering Tirzepatide
Written by TitrateLab, separately from the study summarized above.
